SCHEMBL6340998

SCHEMBL6340998

Nc1ccc(C(=O)N2CCc3c(n(Cc4ccc(O)cc4)c4ccccc34)C2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14489611 1.00 — —
SCHEMBL30583153 0.95 — —
SCHEMBL6335541 0.95 — —
SCHEMBL6337997 0.92 — —
SCHEMBL6335326 0.91 — —
SCHEMBL6335120 0.90 — —
SCHEMBL6413729 0.88 — —
SCHEMBL6333271 0.87 — —
SCHEMBL6338023 0.87 — —
SCHEMBL6335802 0.87 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6964970-B2 Antibacterial compounds AFFINIUM PHARMACEUTICALS, INC. (CA) 2005-11-15 — — US claimed
EP-1180030-B1 ANTIBACTERIAL COMPOUNDS AFFINIUM PHARM INC (CA) 2004-11-24 — — EP claimed
US-20030232850-A1 Antibacterial compounds DEBIOPHARM INTERNATIONAL SA (CH) 2003-12-18 — — US claimed
Send feedback